This week’s MCR Ready Reckoner has been updated and is now available to download or you can view it via the App.
As a part of our work with the Scottish Government and Public Health Scotland, we regularly raise lines of concern and work to secure adjusted prices for these. We also work with them regularly to review lines which have now stabilised and remove these as appropriate.
This Circular advises community pharmacy contractors of a new Universal Claim Framework (UCF) module that will be available for use by providers of Pharmacy First Plus from 1 February 2025.
At Community Pharmacy Scotland, we want to ensure the courier service runs as smoothly as possible for all our members. Below are some key reminders and tips to help avoid delays and ensure your prescription submissions are handled efficiently.
Here is a round-up of all the important news this week, including the latest updates on Independent Prescribing and Community Pharmacy vacancies within the network.
This Circular advises community pharmacy contractors that the Serious Shortage Protocol for isosorbide mononitrate (Monomax® XL) 60mg modified release tablet due to expire on 18 October 2024 has been extended until Friday 15 November 2024.
Here is a round-up of all the important news this week, including the latest updates on Independent Prescribing and Community Pharmacy vacancies within the network.
Our colleagues at ARHAI Scotland have asked for us to promote their latest winter preparedness campaign for the community pharmacy network.
Our colleagues at Scottish Government have asked us to share the 'Keep Antibiotics Working' Campaign, which aims to promote safe and sustainable antibiotics use ahead of this year's World Antimicrobial Awareness Week 2024.
We want to be able to keep in touch with you, so please let us know if your details change, and we will update your details at CPS, and store them securely.
The following are the Top Three items currently under discussion and review by your CPS Board. There is no specific detail, yet, as these are currently “works in progress”. Further detail will follow as available.
Your next Parcelforce prescription collection is coming up on Thursday, 17th October 2024. You should have your prescriptions counted, and in the Parcelforce bag along with your GP34 ready for the driver to collect.
This Circular advises community pharmacy contractors of an updated Patient Group Direction (PGD) that is to be implemented for the provision of desogestrel as bridging contraception.
Here is a round-up of all the important news this week, including the latest updates on Independent Prescribing and Community Pharmacy vacancies within the network.
Community Pharmacy Scotland (CPS) is seeking to recruit at least 100 individuals with an interest in women’s health for a study conducted through a bespoke smartphone app developed specifically for this research.
There are a number of different groups of CPIPs who have undertaken CP IP training over recent years. The attached document gives relevant information on Clinical Skills Training and Teach & Treat for each group.
Congratulations to everyone who has recently passed their IP Courses. Well done! Once you have had the chance to celebrate, here are some details for next steps.
National Education for Scotland (NES) Teach and Treat for Common Clinical Conditions is delivered for community pharmacists, by community pharmacists. It is quality assured experiential learning for newly qualified CPIPs, delivered in designated community pharmacies across Scotland by our Hub Lead Pharmacists (who are also experienced Community Pharmacist Independent Prescribers).
For the attention of all NES/CPS Funded Community Pharmacy Independent Prescribers Qualifying since 2020.
We are pleased to confirm that a new Teach & Treat site will go live in Glasgow early in 2025. This will provide another location for the delivery of this excellent service for our newly qualified Community Pharmacy Independent Prescriber employees. Look out for more detail later in the year.
This Circular advises community pharmacy contractors of changes to NHS prescription stationery for the CP4/3 prescription form.
Here is a round-up of all the important news this week, including the latest updates on Independent Prescribing within the network onThursday, 3rd October 2024.
The new updated version of Part 7 is now available for October 2024. In this month there are four additions and two deletions from the drug tariff we wanted to make you aware of.
Your next Parcelforce prescription collection is coming up on Thursday, 3rd October 2024.
Here is a round-up of all the important news this week, including the latest updates on Independent Prescribing within the network. Thursday, 26th September 2024
There is a new pharmacy poster campaign running from Monday 30th September.
From 4th November 2024, the Ask for ANI scheme will no longer be available in community pharmacies. The public can continue to use the scheme until that date.
This consultation seeks views on the proposal to make a permanent order to come into force when the second emergency order to prevent new patients aged under 18 from beginning to take puberty blockers for the purposes of gender incongruence and/or gender dysphoria, under the care of private prescribers expires.
To advise of a Serious Shortage Protocol (SSP) in place for isosorbide mononitrate (Chemydur® 60XL) modified release tablet, from 6 September 2024 to 27 September 2024.
This Circular advises community pharmacy contractors of a new Universal Claim Framework (UCF) module that will be available for use by providers of Pharmacy First Plus from 1 February 2025.
This Circular advises community pharmacy contractors that the Serious Shortage Protocol for isosorbide mononitrate (Monomax® XL) 60mg modified release tablet due to expire on 18 October 2024 has been extended until Friday 15 November 2024.
This Circular advises community pharmacy contractors of an updated Patient Group Direction (PGD) that is to be implemented for the provision of desogestrel as bridging contraception.
This Circular advises community pharmacy contractors of changes to NHS prescription stationery for the CP4/3 prescription form.
This circular sets out to community pharmacy contractors the details of the community pharmacy funding arrangement for 2024/25.
To advise of a Serious Shortage Protocol (SSP) in place for isosorbide mononitrate (Chemydur® 60XL) modified release tablet, from 6 September 2024 to 27 September 2024.
This Circular advises contractors of a balancing payment relating to the 2023/24 global sum, which will be made along with September’s payments.
To advise of a Serious Shortage Protocol (SSP) in place for cefalexin 500mg tablets, from 6 August 2024 to 27 September 2024.
To advise of a Serious Shortage Protocol (SSP) in place for ramipril 2.5mg tablets, from 6 August 2024 to 15 November 2024.
The Scottish Government have released Circulars PCA(2024)12 through to 20 advising of Serious Shortage Protocols (SSPs) that are in place in relation to supply issues with Quetiapine 150mg, 200mg and 300mg tablets.
This Circular advises community pharmacy contractors that the two UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin antibiotic products due to expire on 21 June 2024 have now been extended until Friday 19 July 2024.
This Circular advises Health Boards and community pharmacy contractors that a series of Public Health Service (PHS) poster campaigns is planned to be distributed to pharmacies over the course of 2024/25
This Circular advises Health Boards and community pharmacy contractors that the two UK-wide Serious Shortage Protocols (SSPs) for Clarithromycin 125mg/5ml and 250mg/5ml oral suspension have been reactivated on 22 May 2024. The new end date for both SSPs is now 21 June 2024.
To advise of a Serious Shortage Protocol (SSP) in place for Creon® 25000 gastro-resistant capsules, from 24 May 2024 to 22 November 2024.
To advise of a Serious Shortage Protocol (SSP) in place for Creon® 10000 gastro-resistant capsules, from 24 May 2024 to 22 November 2024.
This circular advises community pharmacy contractors and NHS Boards on the amendments to the Drug Tariff Part 11 clawback scale.
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for isosorbide mononitrate (Monomil® XL) 60mg modified release tablet due to expire on 3 May 2024 has been extended until Friday 31 May 2024.
This Circular encloses new guidance for dispensing General Practises across Scotland.
To advise of a Serious Shortage Protocol (SSP) in place for isosorbide mononitrate (Monomil® XL) 60mg modified release tablet, from 26 March 2024 to 3 May 2024.
This Circular advises Health Boards and community pharmacy contractors of updated Patient Group Directions (PGDs) that are to be implemented for the treatment of shingles and skin infections under NHS Pharmacy First Scotland.
This Circular advises NHS Boards and healthcare professionals that print copies of the British National Formulary (BNF) and BNF for Children (BNFC) will no longer be provided
PCA(P)(2023)46 - Pharmaceutical Services Amendments To The Drug Tariff Part 11 Discount Clawback Scale
This Circular provides updated guidance aimed at both community optometry and community pharmacy teams and an updated referral form for the assessment and treatment of minor eye conditions.
This circular advises community pharmacy contractors and Health Boards of a corrective payment in order to deliver contractual requirements for the financial year 2023/24.
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for Clarithromycin
This circular informs NHS Boards and community pharmacy contractors of the intention to continue funding for Community Pharmacist Practitioner Champions in 2023-24.
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide Serious Shortage Protocol (SSP) for Clarithromycin
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Estradot®
This Circular advises NHS Boards and community pharmacy contractors of the next Public Health Service (PHS) poster campaign topics which will be distributed to pharmacies.
This Circular advises NHS Boards and community pharmacy contractors that the UK-wide active Serious Shortage Protocol (SSP) for Jext® 300 micrograms/ 0.3mL (1 in 1000) solution for injection auto-injector pen
There has been an update to the NHS Pharmacy First Scotland Approved List.
Community Pharmacy Scotland has been made aware of confusion around some of the NHS Pharmacy First Scotland service (PFS) Urinary Tract Infection (UTI) Patient Group Direction (PGD) details. We thought it would be useful to clarify these points.
Our colleagues at Scottish Government have produced an NHS Pharmacy First Scotland Service Communications Toolkit to help promote Pharmacy First services in Scotland. There are two kits available: one specifically for women's health services and one for general services.
There has been an update to the respiratory section of the NHS Pharmacy First (Scotland) Service Approved List of Products. This means that there are no longer any products listed under cough. It was agreed to remove Simple linctus sugar free, all pack sizes.
There has been an update to the NHS Pharmacy First Scotland Approved List.
guidance for the NHS Pharmacy First Scotland (NHS PFS) service, which is in response to previous questions and outcomes from live events held with the community pharmacy network.
Referrals into community pharmacy from other healthcare professionals are becoming more frequent as community pharmacy services become more well known. This may result in an increase in recommendations to patients from other healthcare professionals when referring them to the community pharmacy for care.
The Scottish Government have updated the NHS Pharmacy First Approved List and to follow national prescribing guidance Simple Linctus sugar-free and Simple Linctus Paediatric sugar-free have now been removed from this list.
The update is to Section 10 Skin to remove Epimax Ointment and Epimax Paraffin free Ointment from NHS Grampian’s list only.
The NHS Pharmacy First Scotland Service approved list of products has been updated as of 1st of April 2024.
This Circular advises Health Boards and community pharmacy contractors of updated Patient Group Directions (PGDs) that are to be implemented for the treatment of shingles and skin infections under NHS Pharmacy First Scotland.
We have been working with Scottish Government and NHS colleagues on trying to capture Pharmacy First Plus prescribing, advice and referrals data to better evidence the great work being done out in the network – at the moment, this cannot be separated out from standard Pharmacy First activity.
As some of you may be aware, NHS England are due to launch the NHS Pharmacy First service in English community pharmacies on 31st of January 2024.
Each local NHS Health Board has the ability to develop bespoke local pharmacy services to suit the needs of local communities and patients
This Circular provides updated guidance aimed at both community optometry and community pharmacy teams and an updated referral form for the assessment and treatment of minor eye conditions.
Patient Group Directions (PGDs) that are to be added to the NHS Pharmacy First Scotland service for the treatment of seasonal allergic rhinitis (hay fever).
This Circular advises Health Boards and community pharmacy contractors of updated Patient Group Directions (PGDs) that are to be implemented for the treatment of urinary tract infections (UTI) and impetigo under NHS Pharmacy First Scotland.
As part of a move to a regional formulary review process in the East of Scotland, both NHS Lothian and NHS Borders will very shortly inform contractors that the dose of Flucloxacillin permitted
Our colleagues in Primary Care have highlighted the attached website as a source of information for professionals and patients which you may find useful in your practice, and Pharmacy First and First Plus in particular.
Circular PCA(P)(2021)5 set out the arrangements for the settlement for pharmaceutical services for the period 2020-21, including for NHS Pharmacy First Scotland.
Since its launch in the midst of the pandemic, you and your teams have supported the people of Scotland with their minor health conditions over 2 million times!
With the Revised List of Approved List Products (PCA (P) (2021) 14) Circular, from 1st October 2021
This Circular encloses a revised Approved List of Products for the NHS Pharmacy First Scotland service, which will come into force from 1st October 2021.
Circular PCA(P)(2021)07 advises that Patient Group Directions (PGDs) supporting two further common clinical conditions will be added to the NHS Pharmacy First Scotland service.
This Circular provides information for community optometry teams about the NHS Pharmacy First Scotland (NHS PFS) service. It also provides guidance aimed at both community optometry and community pharmacy teams and a referral form for the assessment and treatment of minor eye conditions.
This circular informs NHS Boards and community pharmacy contractors of the intention to establish a combined National Foundation Programme and Independent Prescriber (IP) Career Pathway for community pharmacists.
On 24 March 2020, Scottish Government announced support to self-isolate to those at a very high risk of severe illness from COVID-19. This includes providing help to access medicines and food supplies. An extension to this shielding period to at least 31 July 2020 was further announced on 8 June 2020.
This circular encloses amendments to the Health Board Additional Pharmaceutical Services (Minor Ailment Service (Scotland) Directions 2016 for the Minor Ailment Service (MAS) in respect of eligibility for the service, which come into effect on 1 April 2020
This Circular advises community pharmacy contractors and NHS Boards of a one-off payment available to community pharmacy contractors to cover the completion of e-learning modules for the roll-out of the new NHS Pharmacy First Scotland service.
Community Pharmacy Scotland is delighted to highlight this report into the ART (Advice, Referral and Treatment) of pharmacy within the community setting.
There has been an update to the NHS Pharmacy First Scotland Approved List products with the removal of Arjun ear drops 10 ml as this product has been discontinued.